Urothelial carcinoma with divergent histologic differentiation (mixed histologic features) predicts the presence of locally advanced bladder cancer when detected at …
MJ Wasco, S Daignault, Y Zhang, LP Kunju… - Urology, 2007 - Elsevier
OBJECTIVES: The histologic classification of bladder tumors remains an important predictor
of treatment response and patient outcome, with pure nonurothelial tumors associated with …
of treatment response and patient outcome, with pure nonurothelial tumors associated with …
Diagnosis of “poorly formed glands” Gleason pattern 4 prostatic adenocarcinoma on needle biopsy: an interobserver reproducibility study among urologic pathologists …
…, L Cheng, L Egevad, FM Deng, LP Kunju… - The American journal …, 2015 - journals.lww.com
Accurate recognition of Gleason pattern (GP) 4 prostate carcinoma (PCa) on needle biopsy
is critical for patient management and prognostication.“Poorly formed glands” are the most …
is critical for patient management and prognostication.“Poorly formed glands” are the most …
18F-choline PET/MRI: the additional value of PET for MRI-guided transrectal prostate biopsies
M Piert, J Montgomery, LP Kunju… - Journal of Nuclear …, 2016 - Soc Nuclear Med
We assessed the value of fusion 18 F-fluoromethylcholine ( 18 F-choline) PET/MRI for image-guided
(targeted) prostate biopsies to detect significant prostate cancer (Gleason ≥ 3 + 4) …
(targeted) prostate biopsies to detect significant prostate cancer (Gleason ≥ 3 + 4) …
Intraductal carcinoma of the prostate: morphologic features, differential diagnoses, significance, and reporting practices
M Magers, LP Kunju, A Wu - Archives of pathology & …, 2015 - search.proquest.com
The differential diagnosis for atypical cribriform lesions of the prostate has become
increasingly complex and includes intraductal carcinoma of the prostate, high-grade prostatic …
increasingly complex and includes intraductal carcinoma of the prostate, high-grade prostatic …
[HTML][HTML] Accuracy of tumor segmentation from multi-parametric prostate MRI and 18F-choline PET/CT for focal prostate cancer therapy applications
M Piert, PR Shankar, J Montgomery, LP Kunju… - EJNMMI research, 2018 - Springer
Background The study aims to assess the accuracy of multi-parametric prostate MRI (mpMRI)
and 18 F-choline PET/CT in tumor segmentation for clinically significant prostate cancer. F-…
and 18 F-choline PET/CT in tumor segmentation for clinically significant prostate cancer. F-…
Abiraterone+ prednisone (Abi)+/-veliparib (Vel) for patients (pts) with metastatic castration-resistant prostate cancer (CRPC): NCI 9012 updated clinical and genomics …
…, P Twardowski, C Albany, MN Stein, LP Kunju… - 2017 - ascopubs.org
5001 Background: In preclinical CRPC models, PARP1 inhibition synergizes with AR targeted
therapy, especially in ETS fusion-positive tumors. We hypothesized: 1. Co-targeting PARP-…
therapy, especially in ETS fusion-positive tumors. We hypothesized: 1. Co-targeting PARP-…
18F-choline PET/mpMRI for detection of clinically significant prostate cancer: part 2. Cost-effectiveness analysis
…, MS Davenport, JS Montgomery, LP Kunju… - Journal of Nuclear …, 2019 - Soc Nuclear Med
The objective of this study was to evaluate the cost-effectiveness of 18 F-choline PET/multiparametric
MRI (mpMRI) versus mpMRI alone for the detection of primary prostate cancer with …
MRI (mpMRI) versus mpMRI alone for the detection of primary prostate cancer with …
Characterization of glycine‐N‐acyltransferase like 1 (GLYATL1) in prostate cancer
…, BVSK Chakravarthi, LP Kunju… - The …, 2019 - Wiley Online Library
Background Recent microarray and sequencing studies of prostate cancer showed multiple
molecular alterations during cancer progression. It is critical to evaluate these molecular …
molecular alterations during cancer progression. It is critical to evaluate these molecular …
18F-choline PET/mpMRI for detection of clinically significant prostate cancer: part 1. Improved risk stratification for MRI-guided transrectal prostate biopsies
MS Davenport, JS Montgomery, LP Kunju… - Journal of Nuclear …, 2020 - Soc Nuclear Med
A prospective single-arm clinical trial was conducted to determine whether 18 F-choline PET/mpMRI
can improve the specificity of multiparametric MRI (mpMRI) of the prostate for …
can improve the specificity of multiparametric MRI (mpMRI) of the prostate for …
Preclinical evaluation of 11C-sarcosine as a substrate of proton-coupled amino acid transporters and first human application in prostate cancer
…, MS Davenport, J Montgomery, LP Kunju… - Journal of Nuclear …, 2017 - Soc Nuclear Med
Sarcosine is a known substrate of proton-coupled amino acid transporters (PATs), which are
overexpressed in selected tissues and solid tumors. Sarcosine, an N-methyl derivative of …
overexpressed in selected tissues and solid tumors. Sarcosine, an N-methyl derivative of …